Financial Evaluation Of The Synergy Effect Of Fosun Pharma’s Acquisition Of Gland Pharma

With the increasing scale of China’s aging population,the gradual improvement of medical conditions and the improvement of the people’s requirements for medical standards,China’s pharmaceutical companies are gradually moving towards deep water reform.Since 2013,some Chinese pharmaceutical companies have designated overseas capital expansion as their business development strategy,which has accelerated the pace of overseas mergers and acquisitions,and rapidly increased the amount and quantity of overseas mergers and acquisitions by pharmaceutical companies.The pharmaceutical industry is highly dependent on sufficient cash flow and advanced technology,so it has high industry barriers.As the leading enterprise in China’s pharmaceutical industry,Fosun Pharma has upheld the strategy of overseas mergers and acquisitions after 2013 and has been active in overseas capital markets,forming an enterprise structure with the entire industry chain centered on the pharmaceutical industry.This article takes Fosun Pharma’s merger and acquisition of Gland Pharma as the research object,on the basis of elaborating the corporate profiles of Fosun Pharma and Gland Pharma,Fosun Pharma’s motivation and merger process and program of Gland Pharma’s merger and acquisition,from the financial perspective,from the perspective of business coordination and management The three dimensions of synergy and financial synergy are used to construct the financial evaluation index system.AHP is used to conduct a comprehensive evaluation and analysis of synergy effects through vertical comparison of financial indicators before and after mergers and acquisitions and horizontal comparison with the same industry.The single-dimensional synergy effect analysis of the three dimensions of synergy and financial synergy,combined with the evaluation results of Fosun Pharma’s merger and acquisition of Gland Pharma and the cause analysis,proposes strategies for enhancing the synergy effect of overseas mergers and acquisitions of pharmaceutical companies.The research in this article can provide a reference for the analysis and evaluation of the synergy effect of overseas mergers and acquisitions of pharmaceutical companies,and has important theoretical and practical significance for improving the success rate and financial performance of overseas mergers and acquisitions of pharmaceutical companies.